Cutaneous adverse drug reactions: A 9-year study from a South Indian Hospital

Pharmacoepidemiology and Drug Safety

Volumn 14, Issue 8, 2005, Pages 567-570

  Sushma, M ^a   Noel, M V ^a   Ritika, M C ^a   James, J ^a   Guido, S ^a  

^a ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

Author keywords

Cutaneous adverse drug reactions; Fixed drug eruption; Maculopapular rash; Stevens Johnson syndrome

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; CARBAMAZEPINE; CEPHALOSPORIN DERIVATIVE; DAPSONE; DICLOFENAC; DIPYRONE; IBUPROFEN; MACROLIDE; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PENICILLIN DERIVATIVE; PHENOBARBITAL; PHENYTOIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFONAMIDE; TETRACYCLINE DERIVATIVE;

ADULT; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DERMATOLOGY; DISEASE ASSOCIATION; DRUG CLASSIFICATION; DRUG ERUPTION; DRUG HYPERSENSITIVITY; ERYTHEMA MULTIFORME; EXFOLIATIVE DERMATITIS; FEMALE; GROUPS BY AGE; HOSPITAL DEPARTMENT; HOSPITAL PATIENT; HUMAN; INCIDENCE; INDIA; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MEDICAL SCHOOL; PAPULE; PHOTODERMATOSIS; PRIORITY JOURNAL; PUBLICATION; REACTION TIME; RETROSPECTIVE STUDY; SKIN DISEASE; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS; URTICARIA; WORLD HEALTH ORGANIZATION;

ADULT; DRUG ERUPTIONS; DRUG HYPERSENSITIVITY; FEMALE; HOSPITALS, TEACHING; HUMANS; INDIA; MALE; RETROSPECTIVE STUDIES; SKIN;

EID: 23844443185     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/pds.1105     Document Type: Article

References (14)

1. Nerurkar RP, Nadkar MY, Bichile SK. Need for monitoring adverse drug reactions. JAPI 1998; 46: 673-674.
2. Stern RS, Steinberg LA. Epidemiology of adverse cutaneous reactions to drugs. Dermatoepidemiology 1995; 13: 681-688.
3. Kramer MS, Leventhal JM, Hutchison TA, Feinstein AR. An algorithm for the operational assessment of adverse drug reactions. Background description and instruction for use. JAMA 1979; 242: 623-632.
4. Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis and management. Lancet 2000; 356: 1255-1259.
5. Knowles S, Shapiro L, Shear NH. Drug eruptions. Curr Probl Dermatol 2000; 12: 58-62.
6. Shear NH, Knowles SR, Sullivan JR, Shapiro L. Cutaneous reactions to drugs. In Fitzpatrick's Dermatology in General Medicine (6th edn), Freedberg IM, Eisen AZ, Wolff K, et al. (eds). McGraw Hill, Medical publishing division: USA, 2003; 1330-1336.
7. Sharma VK, Sethuram G, Kumar B. Cutaneous adverse drug reactions: clinical pattern and causative agents - a 6 year series from Chandigarh, India. J Postgrad Med 2001; 47: 95-99.
8. Mani MZ, Mathew M. A study of 218 drug eruptions. Indian J Dermatol Venereol Lepr 1983; 49: 109-117.
9. Puavilai S, Timpatanapong P. Prospective study of cutaneous drug reactions. J Med Assoc Thai 1989; 72: 167-171.
10. Naldi L, Conforti A, Venegoni M, Troncon MG, Caputi A, Ghiotto E, Cocci A, Moretti U, Velo G, Leone R. Cutaneous reactions to drugs. An analysis of spontaneous reports in four Italian regions. Br J Clin Pharmacol 1999; 48: 839-846.
11. Hunziker T, Kunzi UP, Braunschweig S, Zehnder D, Hoigne R. Comprehensive hospital drug monitoring (CHDM): adverse skin reactions, a 20-year survey. Allergy 1997; 52: 388-393.
12. Thong BY, Leong KP, Tang CY, Chng HH. Drug allergy in a general hospital: results of a novel prospective inpatient reporting system. Ann Allergy Asthma Immunol 2003; 90: 342-347.
13. Kamalaiah MD, Zainal D, Mokhtar N, Nazmi N. Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in northeastern Malaysia. Int J Dermatol 1998; 37: 520-523.
14. Kumar RH, Kumar MV, Thappa DM. Dapsone syndrome - a five year retrospective analysis. Indian J Lepr 1998; 70: 271-275.